Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2006 1
2007 2
2008 1
2009 1
2010 1
2011 2
2012 2
2013 2
2014 3
2015 3
2016 1
2017 1
2018 4
2019 1
2020 2
2021 2
2022 1
2023 2
2024 2
2025 3
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Modeling Influenza Virus Infection: A Roadmap for Influenza Research.
Boianelli A, Nguyen VK, Ebensen T, Schulze K, Wilk E, Sharma N, Stegemann-Koniszewski S, Bruder D, Toapanta FR, Guzmán CA, Meyer-Hermann M, Hernandez-Vargas EA. Boianelli A, et al. Among authors: toapanta fr. Viruses. 2015 Oct 12;7(10):5274-304. doi: 10.3390/v7102875. Viruses. 2015. PMID: 26473911 Free PMC article. Review.
An intranasal adjuvanted, recombinant influenza A/H5 vaccine primes against diverse H5N1 clades: a phase I trial.
Deming ME, Toapanta FR, Pasetti M, Golding H, Khurana S, Hamouda T, Fattom A, Liang Y, Tennant SM, McGilvray MF, Bernal PJ, Oshinsky JJ, Datta S, Booth JP, Coughlan L, Neuzil KM, Costley CD, Kotloff KL, Sztein MB, Ortiz JR; rH5 Writing Group. Deming ME, et al. Among authors: toapanta fr. Nat Commun. 2025 Nov 6;16(1):9321. doi: 10.1038/s41467-025-64686-3. Nat Commun. 2025. PMID: 41198655 Free PMC article. Clinical Trial.
An intranasal adjuvanted, recombinant influenza A/H5 vaccine candidate induces broad priming against diverse influenza A/H5N1 virus clades in a phase I randomized trial in healthy adults.
Deming ME, Toapanta FR, Pasetti M, Golding H, Khurana S, Hamouda T, Fattom A, Liang Y, Tennant SM, McGilvray MF, Bernal PJ, Oshinsky JJ, Datta S, Booth JP, Coughlan L, Neuzil KM, Costley CD, Kotloff KL, Sztein MB, Ortiz JR. Deming ME, et al. Among authors: toapanta fr. Res Sq [Preprint]. 2025 Mar 5:rs.3.rs-6059149. doi: 10.21203/rs.3.rs-6059149/v1. Res Sq. 2025. Update in: Nat Commun. 2025 Nov 6;16(1):9321. doi: 10.1038/s41467-025-64686-3. PMID: 40092447 Free PMC article. Updated. Preprint.
B and T Cell Immunity in Tissues and Across the Ages.
Booth JS, Toapanta FR. Booth JS, et al. Among authors: toapanta fr. Vaccines (Basel). 2021 Jan 6;9(1):24. doi: 10.3390/vaccines9010024. Vaccines (Basel). 2021. PMID: 33419014 Free PMC article. Review.
Role of antigen specific T and B cells in systemic and mucosal immune responses in ETEC and Shigella infections, and their potential to serve as correlates of protection in vaccine development.
Mani S, Toapanta FR, McArthur MA, Qadri F, Svennerholm AM, Devriendt B, Phalipon A, Cohen D, Sztein MB. Mani S, et al. Among authors: toapanta fr. Vaccine. 2019 Aug 7;37(34):4787-4793. doi: 10.1016/j.vaccine.2019.03.040. Epub 2019 Jun 20. Vaccine. 2019. PMID: 31230883 Free PMC article. Review.
Cord blood innate-like T cell responses in neonates born to healthy women and women living with HIV.
Rach D, Hsu HT, Nampota-Nkomba N, Mvula G, Mkandawire FA, Nyirenda OM, Hritzo B, Boldrin F, Degiacomi G, Mazzabò LC, Manganelli R, Buchwald AG, Toapanta FR, Sztein MB, Laufer MK, Lyke KE, Cairo C. Rach D, et al. Among authors: toapanta fr. Front Immunol. 2025 Aug 22;16:1628145. doi: 10.3389/fimmu.2025.1628145. eCollection 2025. Front Immunol. 2025. PMID: 40918102 Free PMC article.
38 results